Open AccessA rare localization of tuberculosis under infliximab treatment: Testicular involvement
Author(s) -
Mehmet Nayımoğlu,
Banu Sarıfakıoğlu,
Kübra Ustaömer,
Murat Akgül,
Ayşegül İsal Arslan
Publication year - 2021
Publication title -
turkish journal of physical medicine and rehabilitation :
Language(s) - English
Resource type - Journals
ISSN - 2587-1250
DOI - 10.5606/tftrd.2021.5135
Subject(s) - infliximab , medicine , immunosuppression , tuberculosis , latent tuberculosis , disease , immunology , tumor necrosis factor alpha , gastroenterology , mycobacterium tuberculosis , pathology
Infliximab is an inhibitory of tumor necrosis factor-alpha which is used successfully for the treatment of inflammatory bowel disease and rheumatic disease. It has various side effects including injection-induced reactions, immunosuppression, demyelinating diseases, and cardiac effects. One of the most serious side effects is tuberculosis. In particular, the immunosuppressant drugs have a high risk of reactivating latent tuberculosis infection. Its activation probably may occur as an extra-pulmonary and, occasionally, may result in an unusual infection. Herein, we report a 30-year-old male case treated with infliximab and suffered from isolated testicular tuberculosis.